Further evaluation of the local lymph node assay in the final phase of an international collaborative trial.

E.I. du Pont de Nemours, Inc. Haskell Laboratory, Newark, DE 19711-0050, USA.
Toxicology (Impact Factor: 3.75). 05/1996; 108(1-2):141-52. DOI: 10.1016/0300-483X(95)03279-O
Source: PubMed

ABSTRACT The local lymph node assay (LLNA) is a method used for the prospective identification in mice of chemicals that have the potential to cause skin sensitization. We report here the results of the second and final phase of an international trial in which the performance of the assay has been evaluated using seven test materials in five independent laboratories. The additional chemicals examined here included compounds which are considered less potent allergens than some of those tested in the first phase of the investigation, and includes hexylcinnamic aldehyde (HCA), a chemical recommended by the Organization for Economic Cooperation and Development (OECD) as a positive control for skin sensitization studies. In each laboratory all skin sensitizing chemicals examined (2,4-dinitrochlorobenzene {DNCB}, HCA, oxazolone, isoeugenal and eugenol) elicited positive responses of comparable magnitude as judged by the derived lowest concentration of test chemical required to elicit a 3-fold or greater increase in the proliferative activity of draining lymph node cells compared with vehicle-treated controls. We observed that sodium lauryl sulphate, considered to be a non-sensitizing skin irritant, also induced a positive response in the assay. Para-aminobenzoic acid (pABA), a nonsensitizing chemical, was negative at all test concentrations in each laboratory. Some laboratories incorporated minor modifications into the standard assay procedure, including the evaluation of lymph nodes pooled from individual mice rather than treatment groups and the use of statistical analyses. The use of statistics did not markedly change the determination of the lowest concentration yielding a positive response. These data confirm that the local lymph node assay is robust and yields equivalent results when performed independently.

1 Bookmark
  • International Journal of Toxicology - INT J TOXICOL. 01/1998; 17(3):277-296.
  • [Show abstract] [Hide abstract]
    ABSTRACT: In a world increasingly concerned with safety legislation, we have to improve our comprehension of safety issues, and make this available to our respective colleagues, customers and clients. This safety knowledge may have global, continental, national and local aspects enshrined within it, and it is our duty to become familiar with these requirements and act according to the law, or the spirit of the law. This paper attempts to cover topics around safety and aromatherapy.
    International Journal of Aromatherapy 01/2000; 10(1):16-29.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Retinoids have many beneficial effects on dermatological applications. But, retinoids cause skin irritation. In this study, the safety of retinoids was clarified via both primary skin irritation test in rabbits and sensitization study using an integrated model for the differentiation of chemical-induced allergic and irritant skin reaction (IMDS) , an alternative method to sensitization test. The effects of retinoids on the change of ultraviolet A (UVA) -induced matrix metalloproteinase-1 (MMP-1) in human skin fibroblasts and the modulation of type-1 pN collagen synthesis in hairless mice were examined to clarify the anti-wrinkle effects. All-trans retinol (t-ROL) and its derivative, all-trans retinoic acid (t-RA) , showed mild skin irritation but did not induce the sensitization. t-ROL and t-RA exerted anti-wrinkle effects by inhibiting the UVA-induced MMP-1 in human skin fibroblasts and increasing the type-1 pN collagen synthesis in hairless mice. These findings suggest that retinoids do not induce the allergy, and show anti-wrinkle effects by decreasing MMP-1 activation and increasing collagen synthesis.
    Toxicological research. 03/2010; 26(1):61-66.